Why is Bharat Immunolog falling/rising?

As of 23-Sep, Bharat Immunological & Biological Corporation Ltd is experiencing a decline in its stock price, currently at 21.59, which reflects a decrease of 0.18 or 0.83%. The stock has been underperforming, having fallen consecutively for the last two days with a total return of -1.55% during this period. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also decreased significantly, falling by 47.81% compared to the 5-day average, suggesting a decline in investor participation. There are no positive or negative factors available to provide further context on the stock's recent movement.
Broader Market Context: In comparison to the benchmark Sensex, which has shown a slight decline of 0.34% over the past week, Bharat Immunological has underperformed with a drop of 2.44%. Over the past month, while the Sensex has gained 0.98%, Bharat Immunological has seen a more significant decline of 4.60%. Year-to-date, the stock has decreased by 9.25%, contrasting sharply with the Sensex's increase of 5.07%. This broader market context highlights the challenges faced by Bharat Immunological, as it continues to lag behind both the market and its sector.